triamcinolone diacetate has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank-Piskorska, A; Lypka, A; Malinowski, R; Wasek, Z | 1 |
1 trial(s) available for triamcinolone diacetate and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
[Long-term therapy using beclomethasone preparations in our experience].
Topics: Administration, Inhalation; Adult; Asthma; Beclomethasone; Betamethasone; Bronchi; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Time Factors; Triamcinolone | 1988 |